BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34558728)

  • 21. Screening of a Large Cohort of Asymptomatic SDHx Mutation Carriers in Routine Practice.
    Saie C; Buffet A; Abeillon J; Drui D; Leboulleux S; Bertherat J; Zenaty D; Storey C; Borson-Chazot F; Burnichon N; Vincent M; Favier J; Baudin E; Giraud S; Gimenez-Roqueplo AP; Amar L; Lussey-Lepoutre C
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1301-e1315. PubMed ID: 33247927
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Bayley JP; Bausch B; Jansen JC; Hensen EF; van der Tuin K; Corssmit EP; Devilee P; Neumann HP
    J Med Genet; 2023 Jan; 60(1):25-32. PubMed ID: 34750193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene.
    Rich T; Jackson M; Roman-Gonzalez A; Shah K; Cote GJ; Jimenez C
    Fam Cancer; 2015 Dec; 14(4):615-9. PubMed ID: 26162468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
    Srirangalingam U; Walker L; Khoo B; MacDonald F; Gardner D; Wilkin TJ; Skelly RH; George E; Spooner D; Monson JP; Grossman AB; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):587-96. PubMed ID: 18419787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma.
    Burnichon N; Mazzella JM; Drui D; Amar L; Bertherat J; Coupier I; Delemer B; Guilhem I; Herman P; Kerlan V; Tabarin A; Wion N; Lahlou-Laforet K; Favier J; Gimenez-Roqueplo AP
    J Med Genet; 2017 Feb; 54(2):125-133. PubMed ID: 27856506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Molecular Features of Renal and Pheochromocytoma/Paraganglioma Tumor Association Syndrome (RAPTAS): Case Series and Literature Review.
    Casey RT; Warren AY; Martin JE; Challis BG; Rattenberry E; Whitworth J; Andrews KA; Roberts T; Clark GR; West H; Smith PS; Docquier FM; Rodger F; Murray V; Simpson HL; Wallis Y; Giger O; Tran M; Tomkins S; Stewart GD; Park SM; Woodward ER; Maher ER
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4013-4022. PubMed ID: 28973655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K40E: a novel succinate dehydrogenase (SDH)B mutation causing familial phaeochromocytoma and paraganglioma.
    McDonnell CM; Benn DE; Marsh DJ; Robinson BG; Zacharin MR
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):510-4. PubMed ID: 15473885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
    Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
    Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and clinical aspects of paediatric pheochromocytomas and paragangliomas.
    Petenuci J; Guimaraes AG; Fagundes GFC; Benedetti AFF; Afonso ACF; Pereira MAA; Zerbini MCN; Siqueira S; Yamauchi F; Soares SC; Srougi V; Tanno FY; Chambo JL; Lopes RI; Denes FT; Hoff AO; Latronico AC; Mendonca BB; Fragoso MCBV; Almeida MQ
    Clin Endocrinol (Oxf); 2021 Jul; 95(1):117-124. PubMed ID: 33745191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.
    Buffet A; Burnichon N; Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101416. PubMed ID: 32295730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Unique Case of Metastatic, Functional, Hereditary Paraganglioma Associated With an SDHC Germline Mutation.
    Ong RKS; Flores SK; Reddick RL; Dahia PLM; Shawa H
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2802-2806. PubMed ID: 29878124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composite pheochromocytoma/paraganglioma-ganglioneuroma with a germline SDHC mutation: a first of its kind case report.
    Mahlow J; Sanchez A; Barry M; Sirohi D
    Histopathology; 2022 Nov; 81(5):682-685. PubMed ID: 36045543
    [No Abstract]   [Full Text] [Related]  

  • 34. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the Diagnosis of Endocrine and Non-Endocrine Tumors and Related Syndromes.
    Oudijk L; Gaal J; de Krijger RR
    Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Universal Germline Panel Testing for Individuals With Pheochromocytoma and Paraganglioma Produces High Diagnostic Yield.
    Horton C; LaDuca H; Deckman A; Durda K; Jackson M; Richardson ME; Tian Y; Yussuf A; Jasperson K; Else T
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1917-e1923. PubMed ID: 35026032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
    Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
    J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
    Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
    Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
    Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
    Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary paraganglioma targets diverse paraganglia.
    Baysal BE
    J Med Genet; 2002 Sep; 39(9):617-22. PubMed ID: 12205103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.